|
CA2596506C
(en)
|
2005-02-09 |
2021-04-06 |
Avi Biopharma, Inc. |
Antisense composition and method for treating muscle atrophy
|
|
US8236557B2
(en)
*
|
2008-05-28 |
2012-08-07 |
University Of Missouri-Columbia |
Hybrid-AAV vectors to deliver large gene expression cassette
|
|
US8889641B2
(en)
|
2009-02-11 |
2014-11-18 |
The University Of North Carolina At Chapel Hill |
Modified virus vectors and methods of making and using the same
|
|
EP2524037B1
(en)
|
2010-01-12 |
2018-05-16 |
The University Of North Carolina At Chapel Hill |
Restrictive inverted terminal repeats for viral vectors
|
|
JP6141021B2
(ja)
*
|
2010-02-05 |
2017-06-07 |
ザ・ユニヴァーシティ・オヴ・ノース・キャロライナ・アト・チャペル・ヒル |
パルボウイルスの形質導入を増強するための組成物および方法
|
|
JP6042825B2
(ja)
|
2011-02-10 |
2016-12-14 |
ザ・ユニヴァーシティ・オヴ・ノース・キャロライナ・アト・チャペル・ヒル |
改変された形質導入プロファイルを有するウイルスベクターならびにその製造および使用の方法
|
|
US20130085139A1
(en)
|
2011-10-04 |
2013-04-04 |
Royal Holloway And Bedford New College |
Oligomers
|
|
WO2013075008A1
(en)
|
2011-11-16 |
2013-05-23 |
University Of Florida Research Foundation Inc. |
Aav dual vector systems for gene therapy
|
|
CN103405774A
(zh)
*
|
2012-10-24 |
2013-11-27 |
尹海芳 |
一种新型药物靶向运输辅助剂
|
|
WO2014081855A1
(en)
*
|
2012-11-20 |
2014-05-30 |
Universite De Montreal |
Methods and compositions for muscular dystrophies
|
|
US9624282B2
(en)
*
|
2012-11-26 |
2017-04-18 |
The Curators Of The University Of Missouri |
Microdystrophin peptides and methods for treating muscular dystrophy using the same
|
|
WO2014143932A1
(en)
|
2013-03-15 |
2014-09-18 |
The University Of North Carolina At Chapel Hill |
Synthetic adeno-associated virus inverted terminal repeats
|
|
IL298049B2
(en)
|
2013-03-15 |
2023-10-01 |
Univ North Carolina Chapel Hill |
Methods and compounds for ligation of paired AAV glycan vectors
|
|
US10907176B2
(en)
|
2015-01-14 |
2021-02-02 |
The University Of North Carolina At Chapel Hill |
Methods and compositions for targeted gene transfer
|
|
KR102684387B1
(ko)
*
|
2015-01-16 |
2024-07-11 |
유니버시티 오브 워싱톤 |
신규한 마이크로-디스트로핀 및 관련된 사용 방법
|
|
EP3258961A4
(en)
|
2015-02-20 |
2018-08-22 |
Board of Regents, The University of Texas System |
Methods and compositions for attenuated chlamydia as vaccine and vector
|
|
GB201507842D0
(en)
*
|
2015-05-07 |
2015-06-17 |
New Royal Holloway & Bedford |
Production of large-sized microdystrophins in an AAV-based vector configuration
|
|
EP3831842A1
(en)
|
2015-09-28 |
2021-06-09 |
The University of North Carolina at Chapel Hill |
Methods and compositions for antibody-evading virus vectors
|
|
BR112018007066A2
(pt)
|
2015-10-09 |
2018-10-23 |
Sarepta Therapeutics Inc |
composições e métodos para tratamento da distrofia muscular de duchene e distúrbios relacionados
|
|
SG11201804166YA
(en)
|
2015-11-16 |
2018-06-28 |
Res Inst Nationwide Childrens Hospital |
Materials and methods for treatment of titin-based myopathies and other titinopaties
|
|
CN116478254A
(zh)
|
2015-12-14 |
2023-07-25 |
北卡罗来纳大学教堂山分校 |
增强细小病毒载体递送的修饰衣壳蛋白
|
|
SG11201809029RA
(en)
|
2016-04-15 |
2018-11-29 |
Res Inst Nationwide Childrens Hospital |
Adeno-associated virus vector delivery of b-sarcoglycan and microrna-29 and the treatment of muscular dystrophy
|
|
MA45477A
(fr)
|
2016-04-15 |
2019-02-20 |
Res Inst Nationwide Childrens Hospital |
Administration à vecteurs de virus adéno-associé de microarn-29 et micro-dystrophine pour traiter la dystrophie musculaire
|
|
CA2971303A1
(en)
*
|
2016-06-21 |
2017-12-21 |
Bamboo Therapeutics, Inc. |
Optimized mini-dystrophin genes and expression cassettes and their use
|
|
EP4011206B1
(en)
|
2016-06-21 |
2023-11-01 |
The Curators of the University of Missouri |
Modified dystrophin proteins
|
|
SG11201811603WA
(en)
|
2016-07-26 |
2019-02-27 |
Biomarin Pharm Inc |
Novel adeno-associated virus capsid proteins
|
|
CA3073137A1
(en)
|
2016-08-19 |
2018-02-22 |
Jeffrey S. Bartlett |
Methods and compositions for treating conditions using recombinant self-complementary adeno-associated virus
|
|
KR20190088561A
(ko)
|
2016-12-07 |
2019-07-26 |
유니버시티 오브 플로리다 리서치 파운데이션, 인코포레이티드 |
인터류킨-1 수용체 길항제(IL-1RA) cDNA
|
|
EP3592848A1
(en)
|
2017-03-10 |
2020-01-15 |
Genethon |
Treatment of glycogen storage disease iii
|
|
EP3610023B1
(en)
|
2017-03-15 |
2023-10-04 |
The University of North Carolina at Chapel Hill |
Polyploid adeno-associated virus vectors and methods of making and using the same
|
|
EP3596112A2
(en)
|
2017-03-17 |
2020-01-22 |
Newcastle University |
Adeno-associated virus vector delivery of a fragment of micro-dystrophin to treat muscular dystrophy
|
|
CN110892062A
(zh)
|
2017-05-05 |
2020-03-17 |
佛罗里达大学研究基金会 |
表达耳畸蛋白的组合物和方法
|
|
MA50836A
(fr)
|
2017-10-18 |
2020-08-26 |
Res Inst Nationwide Childrens Hospital |
Administration par vecteur à virus adéno-associé de micro-dystrophine spécifique de muscles pour traiter la dystrophie musculaire
|
|
SG11202006722RA
(en)
|
2018-01-31 |
2020-08-28 |
Res Inst Nationwide Childrens Hospital |
Gene therapy for limb-girdle muscular dystrophy type 2c
|
|
EP3759218A4
(en)
|
2018-02-28 |
2021-12-08 |
The University of North Carolina at Chapel Hill |
PROCEDURES AND COMPOSITIONS FOR ANTIBODY ELIMINATING VIRUS VECTORS
|
|
CN112272672A
(zh)
|
2018-04-03 |
2021-01-26 |
斯特里迪比奥公司 |
抗体逃避性病毒载体
|
|
KR20210006358A
(ko)
|
2018-04-03 |
2021-01-18 |
스트라이드바이오 인코포레이티드 |
안 조직을 표적으로 하기 위한 바이러스 벡터
|
|
JP2021519581A
(ja)
|
2018-04-03 |
2021-08-12 |
ストライドバイオ，インコーポレイテッド |
抗体を回避するウイルスベクター
|
|
JP7575273B2
(ja)
|
2018-04-16 |
2024-10-29 |
ザ・トラステイーズ・オブ・ザ・ユニバーシテイ・オブ・ペンシルベニア |
デュシェンヌ型筋ジストロフィーを治療するための組成物及び方法
|
|
US11660353B2
(en)
|
2018-04-27 |
2023-05-30 |
Decibel Therapeutics, Inc. |
Compositions and methods for treating sensorineural hearing loss using otoferlin dual vector systems
|
|
CN119410636A
(zh)
|
2018-04-27 |
2025-02-11 |
分贝治疗公司 |
肌球蛋白15启动子及其用途
|
|
SG11202010830WA
(en)
|
2018-05-09 |
2020-11-27 |
Biomarin Pharm Inc |
Methods of treating phenylketonuria
|
|
TW202005978A
(zh)
|
2018-05-14 |
2020-02-01 |
美商拜奧馬林製藥公司 |
新穎肝靶向腺相關病毒載體
|
|
US10758629B2
(en)
|
2018-05-29 |
2020-09-01 |
Sarepta Therapeutics, Inc. |
Exon skipping oligomer conjugates for muscular dystrophy
|
|
BR112020025995A2
(pt)
*
|
2018-06-18 |
2021-03-23 |
Research Institute At Nationwide Children's Hospital |
administração de microdistrofina músculo-específica por vetor de vírus adeno-associado para tratar a distrofia muscular
|
|
JP2021528959A
(ja)
|
2018-06-22 |
2021-10-28 |
アスクレピオス バイオファーマシューティカル， インコーポレイテッド |
細胞内で存続する遺伝子送達のためのベクター
|
|
EP3814514A1
(en)
|
2018-06-29 |
2021-05-05 |
Research Institute at Nationwide Children's Hospital |
Recombinant adeno-associated virus products and methods for treating limb girdle muscular dystrophy 2a
|
|
WO2020093018A1
(en)
|
2018-11-01 |
2020-05-07 |
University Of Florida Research Foundation, Incorporated |
A codon optimized otoferlin aav dual vector gene therapy
|
|
CN114072179B
(zh)
|
2019-02-08 |
2024-11-01 |
分贝治疗公司 |
肌球蛋白15启动子及其用途
|
|
EP3921032A4
(en)
|
2019-02-08 |
2022-11-30 |
Decibel Therapeutics, Inc. |
Compositions and methods for treating sensorineural hearing loss using otoferlin dual vector systems
|
|
US12377170B2
(en)
|
2019-02-26 |
2025-08-05 |
Research Institute At Nationwide Children's Hospital |
Adeno-associated virus vector delivery of β-sarcoglycan and the treatment of muscular dystrophy
|
|
AR118465A1
(es)
|
2019-03-21 |
2021-10-06 |
Stridebio Inc |
Vectores de virus adenoasociados recombinantes
|
|
WO2020193636A1
(en)
*
|
2019-03-25 |
2020-10-01 |
Genethon |
Production of large-sized quasidystrophins using overlapping aav vectors
|
|
AU2020263392A1
(en)
|
2019-04-26 |
2021-10-28 |
The University Of North Carolina At Chapel Hill |
Methods and compositions for dual glycan binding AAV2.5 vector
|
|
SG11202113052YA
(en)
|
2019-05-30 |
2021-12-30 |
Solid Biosciences Inc |
Recombinant herpesvirales vector
|
|
KR20220032595A
(ko)
*
|
2019-07-10 |
2022-03-15 |
유니버시티 오브 워싱톤 |
바-바이러스 면역-표적화
|
|
DK4017871T5
(da)
|
2019-08-21 |
2024-08-05 |
Res Inst Nationwide Childrens Hospital |
Adenoassocieret virusvektoradministration af alfa-sarcoglycan og behandling af muskeldystrofi
|
|
US11905523B2
(en)
|
2019-10-17 |
2024-02-20 |
Ginkgo Bioworks, Inc. |
Adeno-associated viral vectors for treatment of Niemann-Pick Disease type-C
|
|
CA3155381A1
(en)
|
2019-11-06 |
2021-05-14 |
Association Institut De Myologie |
Combined therapy for muscular diseases
|
|
BR112022009895A2
(pt)
*
|
2019-11-28 |
2022-08-09 |
Regenxbio Inc |
Construtos de terapia de gene de microdistrofina e usos dos mesmos
|
|
IL295741A
(en)
|
2020-04-01 |
2022-10-01 |
Univ Florida |
Dual aav-myo7a vectors with improved safety for the treatment of ush1b
|
|
CA3174312A1
(en)
|
2020-04-29 |
2021-11-04 |
Glen BANKS |
Miniaturized dystrophins having spectrin fusion domains and uses thereof
|
|
IL300728A
(en)
|
2020-08-19 |
2023-04-01 |
Sarepta Therapeutics Inc |
Adeno-associated virus vectors for the treatment of Rett syndrome
|
|
WO2022076750A2
(en)
|
2020-10-07 |
2022-04-14 |
Regenxbio Inc. |
Recombinant adeno-associated viruses for cns or muscle delivery
|
|
AU2021369480B2
(en)
|
2020-10-28 |
2025-05-22 |
The University Of North Carolina At Chapel Hill |
Methods and compositions for dual glycan binding AAV2.5 vector
|
|
WO2022093769A1
(en)
|
2020-10-28 |
2022-05-05 |
The University Of North Carolina At Chapel Hill |
Methods and compositions for dual glycan binding aav2.5 vector
|
|
TW202242124A
(zh)
|
2021-01-14 |
2022-11-01 |
美商史崔德生物公司 |
靶向ｔ細胞之ａａｖ載體
|
|
WO2022216749A1
(en)
|
2021-04-05 |
2022-10-13 |
Solid Biosciences Inc. |
Recombinant herpesvirales vector
|
|
EP4323015A4
(en)
|
2021-04-16 |
2025-10-22 |
Askbio Inc |
RATIONALLY POLYPLOID AAV VIRIONS CROSS THE BLOOD-BRAIN BARRIER AND TRIGGER A REDUCED HUMORAL RESPONSE
|
|
WO2022232141A1
(en)
*
|
2021-04-26 |
2022-11-03 |
Regenxbio Inc. |
Microdystrophin gene therapy administration for treatment of dystrophinopathies
|
|
US20240390522A1
(en)
*
|
2021-09-28 |
2024-11-28 |
University Of Florida Research Foundation, Incorporated |
Gene therapy for duchenne muscular dystrophy
|
|
US20250001006A1
(en)
|
2021-10-07 |
2025-01-02 |
Regenxbio Inc. |
Recombinant adeno-associated viruses for targeted delivery
|
|
CN115960946A
(zh)
*
|
2021-10-09 |
2023-04-14 |
中国科学院分子植物科学卓越创新中心 |
调节植物镁离子吸收和转运的方法
|
|
US12285497B2
(en)
|
2021-10-15 |
2025-04-29 |
Research Institute At Nationwide Children's Hospital |
Self-complementary adeno-associated virus vector and its use in treatment of muscular dystrophy
|
|
US20250099620A1
(en)
*
|
2022-01-17 |
2025-03-27 |
Dinaqor Ag |
Gene therapy composition and treatment for dystrophin-related cardiomyopathy
|
|
EP4215614A1
(en)
|
2022-01-24 |
2023-07-26 |
Dynacure |
Combination therapy for dystrophin-related diseases
|
|
TW202342759A
(zh)
|
2022-02-04 |
2023-11-01 |
美商史崔德生物公司 |
重組腺相關病毒載體及其使用方法
|
|
WO2023212193A1
(en)
*
|
2022-04-27 |
2023-11-02 |
The Curators Of The University Of Missouri |
Micro-dystrophin for heart protection
|
|
WO2024124019A2
(en)
|
2022-12-07 |
2024-06-13 |
Ginkgo Bioworks, Inc. |
Aav vectors targeting hematopoietic stem cells
|
|
WO2024216244A2
(en)
|
2023-04-13 |
2024-10-17 |
Regenxbio Inc. |
Targeting aav capsids, methods of manufacturing and using same
|
|
WO2025017168A1
(en)
*
|
2023-07-19 |
2025-01-23 |
Genethon |
Novel optimized utrophin micro-genes
|